Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations

Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical Applications   BOSTON and PARIS, June 30, 2021, – Stilla Technologies, the company innovating the [...]

2021-07-01T10:34:31+02:00June 30th, 2021|Press releases|
Read More

Stilla expands leadership team to drive next phase of global commercial growth; appoints Philippe Mourere as President and CEO and Founder Remi Dangla as CTO

Stilla expands leadership team to drive next phase of global commercial growth; appoints Philippe Mourere as President BOSTON, MA and PARIS, FRANCE - February 2, 2021 - Stilla Technologies is pleased to announce the appointment of Mr. Philippe Mourere as its new Chief Executive Officer. Former CEO and Founder Dr. Rémi Dangla has been [...]

2021-02-02T10:06:28+01:00February 2nd, 2021|Press releases|
Read More

Stilla’s & Integrated DNA Technologies’s webinar, Wednesday 3rd of February 2021

February the 3rd 2021 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST),  Design and optimize high multiplexing digital PCR assays with the naica® system by Erik Wendlandt (Integrated DNA Technologies) & Kimberley Gutierrez (Stilla Technologies) Speakers’s Bio Erik Wendlandt Field Applications Scientist Integrated DNA Technologies [...]

2021-04-19T10:12:24+02:00January 14th, 2021|Press releases|
Read More

Stilla Technologies launches its brand-new line of naica® PCR reagents and announces a partnership with ID-Solutions to commercialize the IDENTIFY kit line

Stilla Technologies launches its brand-new line of naica® PCR reagents and announces a partnership with ID-Solutions to commercialize the IDENTIFY kit line The naica® PCR mixes  are specifically developed for optimized Crystal Digital PCR™ assays on the naica® system and the IDENTIFY kit line offers a range of full solutions for digital PCR applications [...]

2020-12-01T10:44:10+01:00December 1st, 2020|Press releases|
Read More

Stilla’s webinar in collaboration with Genomeweb & the Blood Transfusion Service of Zürich, Tuesday 20th of October 2020

October the 20th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST),  Crystal Digital PCR™ for Accurate Chimerism Monitoring after Stem Cell Transplantation by Elise Gourri (National Institute of Biology, Slovenia) & Viviane Sternkopf (Stilla Technologies) Speakers’s Bio Elise Gourri, MSc. Scientist Department of Molecular [...]

2020-10-22T16:41:35+02:00September 10th, 2020|Press releases|
Read More

Stilla Technologies Launches the World’s First Six-Color Digital PCR Instrument

Stilla Technologies Launches the World’s First Six-Color Digital PCR Instrument Key Applications Include Oncology, Infectious Disease and Food Testing Paris, June 9th, 2020 Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, today launched the world’s first six-color digital PCR instrument, the six-color Prism. The instrument expands [...]

2020-06-26T12:08:04+02:00June 9th, 2020|Press releases|
Read More

Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS‐CoV‐2

Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2 The approach significantly reduces costs and increases testing capacity while offering a diagnostic sensitivity greater than the current standard of individual RT-PCR tests Paris, June 5th, [...]

2020-06-18T09:45:44+02:00June 5th, 2020|Press releases|
Read More
Go to Top